RetinaDigest

Weekly curated literature from top retina and ophthalmology journals

63 articles
9 categories
🔬

Retinal Detachment & Trauma11 articles

RRD, TRD, giant tears, PVR, ocular trauma, macular hole, ERM

Delayed Spontaneous Laser-Induced Full-Thickness Macular Hole Closure in a Pediatric Patient.

Chekkoury et al.
Am J OphthalmolFeb 1, 2026

Abstract not available — see full article for details.

View full article

Dissection of Retinal Detachment from Boston Keratoprosthesis Optic: A Novel Surgical Technique.

Oberfeld et al.
Am J OphthalmolFeb 1, 2026

Abstract not available — see full article for details.

View full article

Peripapillary Retinoschisis: The Expanded Spectrum and New Insights From Multimodal Imaging.

Yang et al.
Am J OphthalmolFeb 1, 2026

This multicenter study characterized 47 eyes with peripapillary retinoschisis (PPRS) and identified 9 distinct etiologies that can be classified into 5 major groups, providing a comprehensive framework for diagnosis and management.

View full article

VISUAL AND ANATOMIC OUTCOMES OF VITRECTOMY FOR MYOPIC MACULOSCHISIS WITH AND WITHOUT MACULAR DETACHMENT: A Case-Control Study.

Li et al.
RetinaFeb 1, 2026

This case-control study of 38 eyes found that the presence of macular detachment in myopic maculoschisis patients does not significantly affect postoperative visual or anatomical outcomes following pars plana vitrectomy.

View full article

INNER FOVEAL IRREGULARITIES AFTER VITREOMACULAR DETACHMENT: A Morphologic Risk Factor for Macular Hole Formation in the Fellow Eye.

Klaas et al.
RetinaFeb 1, 2026

Inner foveal irregularity (IFI) after vitreomacular detachment is a significant morphologic risk factor for full-thickness macular hole development in fellow eyes, with a 44.4% cumulative risk at 24 months.

View full article

PORES IN THE RETINAL INNER LIMITING MEMBRANE FORMED BY MÜLLER CELL PROTRUSIONS.

Vogt et al.
RetinaFeb 1, 2026

This study demonstrates that pores in the inner limiting membrane (ILM) are formed by Müller cell processes extending through the ILM toward the vitreous, which may contribute to epiretinal membrane formation.

View full article

HYPERREFLECTIVE RETINAL SPOTS IN EPIRETINAL MEMBRANES: Evolving Significance Across Disease Stages.

Quarta et al.
RetinaFeb 1, 2026

Hyperreflective spots (HRS) on OCT increase with epiretinal membrane severity and correlate with visual function in early stages but not advanced stages, suggesting their utility as early prognostic markers.

View full article

PROGNOSTIC FACTORS FOR DEVELOPMENT OF GLIOSIS AFTER INTERNAL LIMITED MEMBRANE FLAP FOR IDIOPATHIC MACULAR HOLES.

Barayev et al.
RetinaFeb 1, 2026

Gliosis after macular hole surgery with ILM flap technique occurs in 12.3% of cases and is associated with larger hole diameter and worse preoperative visual acuity, though visual improvement still occurs even when gliosis develops.

View full article

HEAVY VERSUS STANDARD SILICONE OIL TAMPONADE IN PRIMARY RETINAL DETACHMENT SURGERY: A Systematic Review and Meta-Analysis.

Carlà et al.
RetinaFeb 1, 2026

Heavy silicone oil (HSO) and standard silicone oil (SSO) demonstrate comparable anatomical success rates and visual outcomes in primary rhegmatogenous retinal detachment surgery, but HSO is associated with significantly higher rates of IOP elevation and emulsification.

View full article

EVALUATING POSTERIOR VITREOUS DETACHMENT ANNOTATION CONSISTENCY ON OPTICAL COHERENCE TOMOGRAPHY SCANS IN PATIENTS WITH DISEASE OF THE VITREOMACULAR INTERFACE.

Ferro Desideri et al.
RetinaFeb 1, 2026

Six experienced ophthalmologists showed only moderate agreement (κ=0.57) when classifying posterior vitreous detachment on SD-OCT in patients with epiretinal membrane and macular hole, with particularly poor agreement for cases without PVD (κ=0.14).

View full article

Can Aqueous Proteomics Predict the Recurrence of Rhegmatogenous Retinal Detachment?

Zingale et al.
RetinaJan 26, 2026

Aqueous humor proteomics analysis identified distinct molecular signatures at the time of primary rhegmatogenous retinal detachment repair that may predict recurrence risk, with upregulated cell adhesion and extracellular matrix proteins in patients who later developed recurrent detachment.

View full article
🩸

Diabetic Eye Disease6 articles

Diabetic retinopathy surgery, DME treatment, tractional complications

Racial and Ethnic Disparities in Risk for Adverse Ocular Events in Patients With Diabetic Retinopathy.

Anozie et al.
Am J OphthalmolFeb 1, 2026

This large retrospective cohort study of 627,434 patients with diabetic retinopathy found significant racial disparities, with Black and Hispanic patients experiencing substantially higher rates of blindness, vitreous hemorrhage, tractional retinal detachment, and diabetic macular edema compared to other racial groups.

View full article

Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-Pan-Retinal Photocoagulation.

He et al.
Am J OphthalmolFeb 1, 2026

UWF-SS OCTA analysis of 44 eyes post-PRP revealed a dual-pathway mechanism where laser-induced choroidal-derived intraretinal neovascularization (CDIRN) compensates for deep capillary plexus ischemia, preserving retinal perfusion while reducing hypoxia.

View full article

Ultra-Widefield Fluorescein Angiographic Quantitative Leakage Parameters and Clinical Outcomes in Nonproliferative Diabetic Retinopathy.

Ehlers et al.
JAMA OphthalmolJan 29, 2026

Ultra-widefield fluorescein angiography leakage index serves as a quantitative biomarker for predicting diabetic retinopathy progression, with baseline leakage and 1-year increases strongly associated with DRSS worsening and vision-threatening complications.

View full article

Automated FA Leakage Measurement to Predict NPDR Progression.

Virgili et al.
JAMA OphthalmolJan 29, 2026

Abstract not available — see full article for details.

View full article

Microaneurysm Reflectivity as a prognostic biomarker for intravitreal Treatment Response in Diabetic Retinopathy.

Viggiano et al.
Am J OphthalmolJan 28, 2026

Baseline microaneurysm reflectivity patterns on SD-OCT predict treatment response in diabetic macular edema, with hyperreflective phenotypes achieving significantly higher complete fluid resolution rates (51.3%) compared to hyporeflective phenotypes (7.4%).

View full article

Outcomes and Complications of Pars Plana Vitrectomy for Non-clearing Vitreous Hemorrhage without Tractional Elements.

Muste et al.
Ophthalmol RetinaJan 28, 2026

This retrospective study of 306 eyes found that preoperative anti-VEGF injections did not improve visual outcomes, reduce recurrent vitreous hemorrhage, or decrease reoperation rates following pars plana vitrectomy for non-clearing vitreous hemorrhage in diabetic retinopathy without tractional detachment.

View full article
👁️

AMD & Macular Degeneration6 articles

Neovascular AMD, geographic atrophy, submacular hemorrhage

EXUDATIVE MACULAR NEOVASCULARIZATION BEFORE VISIBLE PIGMENTATION IN MACULAR TELANGIECTASIA TYPE-2 (MacTel).

Chandran et al.
RetinaFeb 1, 2026

A retrospective analysis of 798 MacTel patients found that 2% developed exudative macular neovascularization (ExMNV) without preceding pigmentation, challenging the traditional disease progression model.

View full article

Association of Migraine With Increased Risk of Central Serous Chorioretinopathy: A Retrospective Cohort Study.

Nitzan et al.
Am J OphthalmolFeb 1, 2026

This large retrospective cohort study of 413,663 matched patients found that migraine is associated with a 2.74-fold increased risk of developing central serous chorioretinopathy (CSCR) over five years.

View full article

THE ROLE OF EN FACE IMAGING OF RETINAL PIGMENT EPITHELIUM ALTERATIONS IN RAPID CLASSIFICATION OF CENTRAL SEROUS CHORIORETINOPATHY USING WIDEFIELD SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY.

Zhang et al.
RetinaFeb 1, 2026

Widefield swept-source OCT en face imaging of RPE alterations provides a reliable, noninvasive method for rapidly classifying central serous chorioretinopathy, detecting RPE abnormalities in 88.2% of complex CSCR cases.

View full article

FREQUENCY OF MISDIAGNOSES AND ASSOCIATED RISK FACTORS IN MACULAR TELANGIECTASIA TYPE 2.

Raming et al.
RetinaFeb 1, 2026

Macular telangiectasia type 2 (MacTel) is frequently misdiagnosed (35.8% of cases), most commonly as macular hole, maculopathy, or AMD, though diagnostic delays have significantly decreased from 115 months (2000-2005) to 5.9 months (after 2020).

View full article

TYPE 4 MACULAR NEOVASCULARIZATION: A New Member of the Optical Coherence Tomography Classification of Neovascularization Age-Related Macular Degeneration.

Chan et al.
RetinaFeb 1, 2026

This study describes Type 4 macular neovascularization (MNV), a new aggressive form of neovascular AMD characterized by mixed Type 1 and 2 neovascularization with extensive intraretinal anastomotic networks and poor visual outcomes despite anti-VEGF therapy.

View full article

Proposal, Derivation, and External Validation of a Novel Geographic Atrophy Outcome Measure.

Hou et al.
JAMA OphthalmolJan 29, 2026

Researchers developed and validated GAWAIN (Geographic Atrophy Weighted-by-Acuity Index), a novel structural outcome measure that better correlates with visual acuity than traditional GA area measurements by weighting macular regions according to their functional importance.

View full article
🫀

Vascular Occlusions5 articles

CRVO, BRVO, retinal ischemia, macular edema from RVO

The Complexity of Retinal Vein Occlusions in Young Patients.

Tsui et al.
RetinaFeb 1, 2026

Abstract not available — see full article for details.

View full article

SYSTEMIC THROMBOEMBOLIC OUTCOMES IN YOUNG PATIENTS AFTER RETINAL VEIN OCCLUSIONS.

Zhang et al.
RetinaFeb 1, 2026

Young patients (18-50 years) with retinal vein occlusions and no identifiable risk factors have significantly increased long-term risk of venous thromboembolism and stroke compared to matched controls.

View full article

LARGE RETINAL CAPILLARY ANEURYSM: Clinical Features, Multimodal Imaging Characteristics, and Treatment Outcomes of Primary and Secondary Lesions.

Tekin et al.
RetinaFeb 1, 2026

Primary and secondary large retinal capillary aneurysms (LRCAs) have similar imaging characteristics but different treatment responses, with secondary lesions showing better outcomes due to differing pathophysiology.

View full article

Embolus Migration and Reperfusion in Central Retinal Artery Occlusion Treated by Intra-Arterial Cannulation.

Tanaka et al.
OphthalmologyFeb 1, 2026

Abstract not available — see full article for details.

View full article

Traumatic Unilateral Peripheral Arteriolar Occlusions.

Rustam et al.
JAMA OphthalmolJan 29, 2026

Abstract not available — see full article for details.

View full article
🧬

Inherited Retinal Disease6 articles

IRDs, gene therapy, retinitis pigmentosa, LCA, Stargardt

Unveiling Inflammation-Like Retinal Remodeling in CRB1-Associated Inherited Retinal Dystrophies: Insights From a Multicenter Study.

Hong et al.
Am J OphthalmolFeb 1, 2026

This multicenter study of 66 CRB1-associated inherited retinal dystrophy patients identified inflammation-like fundus features as core characteristics, with severity correlating to genotype and outer retinal disruption patterns.

View full article

Central Retinal Sensitivity Decline in RPGR-Related Retinal Phenotypes.

Josan et al.
Am J OphthalmolFeb 1, 2026

RPGR cone-rod dystrophy patients show significantly faster central retinal sensitivity decline compared to rod-cone patients, with 2-fold higher annual decline rates and earlier total vision loss.

View full article

CONTRAST SENSITIVITY FUNCTION CORRELATES WITH OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN MACULAR TELANGIECTASIA TYPE 2.

Finn et al.
RetinaFeb 1, 2026

Quantitative contrast sensitivity function testing demonstrates significantly reduced contrast sensitivity in macular telangiectasia type 2 eyes compared to controls, with strong correlations to early structural OCT changes including ellipsoid zone discontinuity and outer retinal alterations.

View full article

FACTORS INFLUENCING THE DELAYED DIAGNOSIS OF STARGARDT DISEASE AND IMPACT ON THERAPEUTIC OPPORTUNITIES.

Li et al.
RetinaFeb 1, 2026

Patients with Stargardt disease experience significant diagnostic delays averaging nearly 11 years from symptom onset to specialist evaluation, with intermediate-onset patients facing the longest delays and progressive vision loss during this period.

View full article

Retinal Findings in Kjellin Syndrome.

Pham et al.
OphthalmologyFeb 1, 2026

Abstract not available — see full article for details.

View full article

Retinal Pigment Epithelial Hamartomas in Familial Adenomatous Polyposis: New Insights Based on Multimodal Imaging of 233 Lesions.

Kong et al.
Ophthalmol RetinaJan 28, 2026

This study of 233 retinal pigment epithelial hamartomas in 12 FAP patients reveals distinctive multimodal imaging features that differentiate these lesions from solitary CHRPE, including bilateral involvement, higher lesion counts, and characteristic depigmented halos.

View full article
👶

Pediatric Retina6 articles

ROP, FEVR, Coats disease, retinoblastoma, pediatric vitreoretinal

Birth Weight and Gestational Age Continue to Inform Retinopathy of Prematurity Risk.

Zhao et al.
Am J OphthalmolFeb 1, 2026

Abstract not available — see full article for details.

View full article

Comparing Rhegmatogenous and Tractional Retinal Detachment in Regressed Retinopathy of Prematurity: An International, Multicenter Study.

Hsu et al.
Am J OphthalmolFeb 1, 2026

Late-onset retinal detachment in regressed ROP is predominantly rhegmatogenous (95%) with favorable surgical outcomes, while tractional detachments require multiple surgeries and have poorer anatomical success rates.

View full article

International Consensuses and Guidelines on Diagnosing and Managing Coats Disease by the Academia Retina Internationalis (ARI), the Asia-Pacific Vitreo-retina Society (APVRS), and the Academy of the Asia-Pacific Professors of Ophthalmology (AAPPO).

Mahesh et al.
Am J OphthalmolFeb 1, 2026

International expert consensus achieved agreement on 92.3% of statements regarding Coats disease diagnosis and management, with remaining controversies in advanced stage treatment and anti-VEGF therapy benefits.

View full article

Treating Retinopathy of Prematurity with Dexamethasone Eye Drops: A Difference-in-Differences Study in Sweden Using Register Data.

Gränse et al.
OphthalmologyFeb 1, 2026

A Swedish register-based study found that topical dexamethasone eye drops significantly reduced the need for traditional ROP treatments (laser or anti-VEGF) in preterm infants with type 2 ROP, with treatment rates dropping from 72% to 13% at the intervention site.

View full article

EXCISION OF EXTENSIVE SUBRETINAL FIBROSIS ASSOCIATED WITH RHEGMATOGENOUS RETINAL DETACHMENTS IN PATIENTS WITH FAMILIAL EXUDATIVE VITREORETINOPATHY.

Kondo et al.
RetinaFeb 1, 2026

En bloc excision of extensive subretinal fibrosis through large retinotomy/retinectomy achieves successful retinal reattachment in FEVR patients with rhegmatogenous retinal detachment, with median final visual acuity of 20/66.

View full article

Fatty Acid Supplementation and Retinopathy of Prematurity: Secondary Analysis of a Randomized Clinical Trial.

Lundgren et al.
JAMA OphthalmolJan 29, 2026

Abstract not available — see full article for details.

View full article
🔥

Posterior Uveitis13 articles

Posterior uveitis, panuveitis, chorioretinitis, CMV retinitis, ocular inflammation

Assessing the Research Impact of U.S. Academic Uveitis Specialists Using the Relative Citation Ratio.

Franco et al.
Am J OphthalmolFeb 1, 2026

This bibliometric analysis of 180 U.S. academic uveitis specialists found a median relative citation ratio of 1.28, indicating above-average research impact with significant variation by career stage and academic rank but no gender differences.

View full article

Idiopathic Multifocal Choroiditis/Punctate Inner Choroidopathy as a Secondary Inflammatory Reaction to Lacquer Cracks: A Structural and Temporal Analysis.

Cicinelli et al.
Am J OphthalmolFeb 1, 2026

A retrospective study of 185 eyes with idiopathic multifocal choroiditis/punctate inner choroidopathy (iMFC/PIC) found that 75% had lesion patterns aligned with lacquer cracks, suggesting a mechanically-induced rather than purely inflammatory etiology in highly myopic patients.

View full article

Clinical Efficacy of Biosimilar Switch of Adalimumab and Infliximab for Noninfectious Uveitis: Systematic Review and Meta-Analysis.

Zhang et al.
Am J OphthalmolFeb 1, 2026

Meta-analysis of 202 patients shows switching from originator to biosimilar TNF-α inhibitors for noninfectious uveitis does not increase flare rates, supporting clinical equivalence of biosimilars.

View full article

Clinical Significance of T-SPOT.TB Test in Patients With Uveitis in South Korea.

Song et al.
Am J OphthalmolFeb 1, 2026

In this South Korean cohort of 382 uveitis patients, T-SPOT.TB positivity (32.7%) was not associated with specific uveitis characteristics or treatment patterns, suggesting it reflects background latent TB infection rather than active ocular involvement.

View full article

Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry.

Gaggiano et al.
Am J OphthalmolFeb 1, 2026

This registry study of 700 patients found that noninfectious uveitis activity varies significantly across reproductive life stages in women, with peaks during early puberty and perimenopause.

View full article

Macular Complications Predict Visual Decline in Punctate Inner Choroidopathy.

Del Fabbro et al.
OphthalmologyFeb 1, 2026

Abstract not available — see full article for details.

View full article

Evaluating the Effectiveness of Escalating to Weekly Adalimumab Dosing for the Treatment of Noninfectious Uveitis: A Multicenter Study.

Pillar et al.
OphthalmologyFeb 1, 2026

Weekly adalimumab dosing achieved treatment success in 52% of patients with noninfectious uveitis inadequately controlled on standard biweekly dosing, with posterior uveitis showing better outcomes than panuveitis.

View full article

EFFICACY AND SAFETY OF SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE IN MIXED ETIOLOGY NONINFECTIOUS CYSTOID MACULAR EDEMA.

Yamamoto et al.
RetinaFeb 1, 2026

Suprachoroidal triamcinolone acetonide demonstrated significant anatomical and functional improvements in 61 eyes with noninfectious cystoid macular edema of mixed etiologies, with complete resolution achieved in 58.6% of cases at 1 month.

View full article

MULTIMODAL IMAGING AND LONG-TERM TREATMENT OUTCOMES OF RELENTLESS PLACOID CHORIORETINITIS.

Govindaraju et al.
RetinaFeb 1, 2026

This retrospective study of 8 patients with relentless placoid chorioretinitis demonstrates that long-term immunosuppressive therapy, particularly methotrexate, can achieve disease control with significant visual improvement (mean 3.4 lines) in all cases.

View full article

REAL-WORLD INCIDENCE AND MANAGEMENT OF OCULAR HYPERTENSION AFTER SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE INJECTION FOR MACULAR EDEMA IN NONINFECTIOUS UVEITIS.

Hamdan et al.
RetinaFeb 1, 2026

Suprachoroidal triamcinolone acetonide injection for uveitic macular edema demonstrated a low 11.8% incidence of ocular hypertension in real-world practice, with patients having prior glaucoma/OHT history at significantly higher risk.

View full article

Hemophagocytic Syndrome in Aggressive Natural Killer Cell Leukemia with Ocular Presentation.

Kishimoto et al.
OphthalmologyFeb 1, 2026

Abstract not available — see full article for details.

View full article

Diagnostic Pars Plana Vitrectomy in Undifferentiated Uveitis: Systematic Review and Meta-Analysis.

Zhang et al.
Ophthalmol RetinaJan 28, 2026

This meta-analysis of 17 studies (1,032 eyes) found that diagnostic pars plana vitrectomy achieved a 45.5% overall diagnostic yield in undifferentiated uveitis, with significantly higher success rates when guided by pre-operative clinical suspicion for infectious or malignant etiologies.

View full article

Risk of Glaucoma in Patients With Idiopathic Non-Infectious Uveitis: A Multi-Institutional Real-World Retrospective Cohort Study.

Liu et al.
Am J OphthalmolJan 25, 2026

Patients with idiopathic non-infectious uveitis have a nearly 10-fold increased risk of developing glaucoma compared to matched controls, with highest risk in the first year after diagnosis and among younger patients with panuveitis.

View full article
🎯

Ocular Oncology5 articles

Uveal melanoma, retinoblastoma, choroidal tumors, ocular metastases

Giant Orbital Rhabdomyosarcoma.

Xu et al.
Am J OphthalmolFeb 1, 2026

Abstract not available — see full article for details.

View full article

A Novel Staging Model for Uveal Melanoma: Combining Tumor Volume, Clinical Factors, and Genetic Alterations in a Danish Cohort.

Nissen et al.
OphthalmologyFeb 1, 2026

A new staging system for uveal melanoma combining tumor volume, clinical factors, and genetic alterations provides superior risk stratification compared to traditional anatomical classification, with tumor volume emerging as a powerful prognostic factor.

View full article

LACK OF COMPLICATIONS OF HIGH-DOSE INTRAVITREAL TOPOTECAN FOR RECURRENT RETINOBLASTOMA IN 81 CONSECUTIVE INJECTIONS.

Shields et al.
RetinaFeb 1, 2026

High-dose intravitreal topotecan (90-100 μg) demonstrated 100% tumor control with no local or systemic complications in 81 consecutive injections for recurrent retinoblastoma across 25 eyes.

View full article

Malignant Transformation of a Kissing Nevus.

Liu et al.
OphthalmologyFeb 1, 2026

Abstract not available — see full article for details.

View full article

IgG4-Positive Ocular Adnexal Extranodal Marginal Zone Lymphoma as an Aggressive Clinical Subtype: Evidence from a 377-Patient Cohort.

Sun et al.
Am J OphthalmolJan 27, 2026

IgG4-positive extranodal marginal zone lymphoma of the ocular adnexa represents an aggressive clinical subtype with more extensive local involvement, higher proliferation rates, and significantly increased recurrence risk compared to IgG4-negative cases.

View full article
⚠️

Complications & Safety5 articles

Endophthalmitis, surgical complications, drug safety, adverse events

Unilateral Superior Corneal Melts With Iris Prolapse After Retinal Surgery in Rheumatoid Arthritis.

Arora et al.
Am J OphthalmolFeb 1, 2026

Abstract not available — see full article for details.

View full article

Nonmydriatic Ocular Fundus Imaging on Consecutive Patients Seeking Treatment at a General Emergency Department with Vision Symptoms.

McHenry et al.
OphthalmologyFeb 1, 2026

A 16-day prospective study found that nonmydriatic fundus photography with OCT identified clinically relevant findings in 64% of emergency department patients presenting with vision symptoms, with posterior segment and neurologic disorders comprising 72% of cases.

View full article

DIRECT POSTERIOR RETINAL INJURY CAUSED BY INTRAVITREAL INJECTIONS: Management and Outcomes From a Vitreoretinal Perspective.

Christou et al.
RetinaFeb 1, 2026

This retrospective case series of 12 eyes documents direct posterior retinal injuries from intravitreal injections, showing that while rare, these complications can lead to retinal detachment with proliferative vitreoretinopathy and require prompt surgical intervention.

View full article

MULTICENTER STUDY OF FACTORS ASSOCIATED WITH VISUAL AND ANATOMIC OUTCOMES OF SUPRACHOROIDAL HEMORRHAGE.

Liu et al.
RetinaFeb 1, 2026

This multicenter retrospective study of 143 eyes with suprachoroidal hemorrhage found that visual prognosis remains guarded, with concurrent retinal detachment predicting worse outcomes and systemic steroids potentially providing modest visual benefit.

View full article

Gonioscopy Unveils Completely Unemulsified Silicone Oil Anterior Chamber Filling with secondary open-angle glaucoma.

Abihaidar et al.
RetinaFeb 1, 2026

Abstract not available — see full article for details.

View full article